Marengo Susan Ruth, Chen Daniel H-C, MacLennan Gregory T, Resnick Martin I, Jacobs Gretta H
Department of Urology, School of Medicine, Case Western Reserve University, Cleveland, Ohop 44106-4931, USA.
J Urol. 2004 Mar;171(3):1304-8. doi: 10.1097/01.ju.0000101046.39244.44.
Unraveling the mechanisms leading to clinically active calcium oxalate (CaOx) stone disease and the development of effective medical therapies to treat it have been hampered by the lack of appropriate animal models. To address this problem we developed a model of hyperoxaluria and calcium oxalate crystal deposition by implanting osmotic minipumps subcutaneously into male rats, that is minipump induced hyperoxaluria and crystal deposition in rats.
Male Harlan-Sprague Dawley rats (225 to 290 gm) were implanted subcutaneously with 1-week 2 ml osmotic minipumps containing 1.5 M potassium oxalate (360 microM KOx/24 hours, [KOx-trt], 11) or phosphate buffered saline (PBS-trt, 9) on days 1 and 7. The 24-hour urine collections were performed on days 0, 4, 7, 11 and 14. Data were analyzed by ANOVA and Tukey's HSD. Urinary crystals were analyzed by light microscopy. Kidneys were harvested on day 14 and processed for light and polarizing microscopy, and RNA analysis.RESULTS Mean overall creatinine excretion +/- SEM (PBS-trt 107 +/- 7 and KOx-trt 123 +/- 6 microM/24 hours, p >0.07) and day 14 serum creatinine (PBS-trt 83 +/- 4 and KOx-trt 83 +/- 5 microM, p >or=0.9) were similar in the 2 treatment groups. Overall urinary volume (PBS-trt 11.3 +/- 0.8 and KOx-trt 18.0 +/- 1.5 ml/24 hours, p <or=0.001) and oxalate (OX) excretion (PBS-trt 9.2 +/- 0.6 and KOx-trt 44 +/- 4.2 microM/24 hours, p <or=0.001) were higher in KOx-trt vs PBS-trt rats. In KOx-trt rats OX excretion on day 0 was significantly less than on any day after implantation (p <or=0.01). All KOx-trt rats excreted calcium oxalate dihydrate crystals by day 4 and had intrarenal deposits of birefringent crystals by day 14. Overall the morphology of kidneys of OX rats was normal, although localized regions of inflammation and tubular debris were occasionally observed. Reverse transcriptase-polymerase chain reaction and Northern blot analysis revealed that the expression of 3 distress molecules tumor necrosis factor receptor, osteopontin and kidney injury molecule were up-regulated in KOx-trt kidneys.
The model of minipump induced hyperoxaluria and crystal deposition in rats reliably induces hyperoxaluria, CaOx crystalluria and CaOx crystal deposition. These characteristics make it an appropriate model for investigations of the effects of OX on renal physiology as well as investigating the efficacy of new therapeutics.
由于缺乏合适的动物模型,导致临床上活跃的草酸钙(CaOx)结石病的发病机制以及治疗该病的有效药物疗法的研发一直受到阻碍。为了解决这个问题,我们通过将渗透微型泵皮下植入雄性大鼠体内,建立了高草酸尿症和草酸钙晶体沉积模型,即微型泵诱导的大鼠高草酸尿症和晶体沉积模型。
在第1天和第7天,将含1.5M草酸钾(360μM KOx/24小时,[KOx-trt],11只)或磷酸盐缓冲盐水(PBS-trt,9只)的1周2ml渗透微型泵皮下植入雄性Harlan-Sprague Dawley大鼠(体重225至
290克)体内。在第0、4、7、11和14天进行24小时尿液收集。数据采用方差分析和Tukey's HSD进行分析。通过光学显微镜分析尿晶体。在第14天收获肾脏,进行光学和偏振显微镜检查以及RNA分析。
两个治疗组的平均总肌酐排泄量±SEM(PBS-trt为107±7,KOx-trt为123±6μM/24小时,p>0.07)和第14天的血清肌酐(PBS-trt为83±4,KOx-trt为83±5μM,p≥0.9)相似。KOx-trt组大鼠的总尿量(PBS-trt为11.3±0.8
,KOx-trt为18.0±1.5ml/24小时,p≤0.001)和草酸盐(OX)排泄量(PBS-trt为9.2±0.6,KOx-trt为44±4.2μM/24小时,p≤0.001)均高于PBS-trt组大鼠。在KOx-trt组大鼠中,第0天的OX排泄量显著低于植入后任何一天(p≤
0.01)。所有KOx-trt组大鼠在第4天排泄出二水草酸钙晶体,到第14天肾内有双折射晶体沉积。总体而言,OX组大鼠肾脏的形态正常,尽管偶尔观察到局部炎症区域和肾小管碎片。逆转录聚合酶链反应和Northern印迹分析显示,KOx-trt组大鼠肾脏中3种应激分子肿瘤坏死因子受体、骨桥蛋白和肾损伤分子的表达上调。
微型泵诱导的大鼠高草酸尿症和晶体沉积模型可靠地诱导了高草酸尿症、CaOx晶体尿和CaOx晶体沉积。这些特征使其成为研究OX对肾脏生理影响以及研究新疗法疗效的合适模型。